Core Viewpoint - The company announced that its stock experienced an abnormal fluctuation, with a cumulative closing price increase exceeding 30% over two consecutive trading days on May 27 and May 28, 2025 [1] Group 1: Stock Performance - The stock price fluctuation is categorized as an abnormal trading situation due to the significant increase in closing prices [1] - The company is monitoring the situation following media reports regarding an explosion incident at a related company, Youdao Chemical Co., Ltd. [1] Group 2: Company Operations - The company has project approval for chlorantraniliprole but has not yet commenced formal production [1] - The impact of the recent explosion incident on the company is considered limited [1] Group 3: Information Disclosure - The company has not identified any undisclosed significant information that may have substantially affected its stock trading price, aside from the aforementioned matters [1]
中旗股份:公司目前有氯虫苯甲酰胺的项目审批手续 但目前并未正式投产